Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs SailPoint Inc. Common Stock (SAIL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs SailPoint Inc. Common Stock — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $105.11 (market cap $8.87B), while SailPoint Inc. Common Stock trades at $19 (market cap $11.03B). The key difference: SailPoint Inc. Common Stock is the larger of the two by market cap, and Kymera Therapeutics Inc. Common Stock is more actively traded (779,107 versus 4,993,232). Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and SailPoint Inc. Common Stock for 0 Days on average.
| KYMR | SAIL | |
|---|---|---|
Market Cap | $8.87B | $11.03B |
Volume | 779,107 | 4,993,232 |
Sector | Health | Technology |
52-Week High | $127.31 | $22.85 |
52-Week Low | $55.80 | $10.49 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $8.26B | $10.72B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About SailPoint Inc. Common Stock
SailPoint, Inc. develops identity security software that helps enterprises manage and govern access to applications and data across users, machines, and AI agents. Its unified identity security platform combines automation and intelligence to control identity-related risk at scale for large organizations.
Read more on SAIL →
